- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
8 result(s) found for: Calcium Oxide.
Displaying page 1 of 1.
EudraCT Number: 2009-017619-14 | Sponsor Protocol Number: EBP_TL_2009 | Start Date*: 2010-03-26 | |||||||||||
Sponsor Name:Medicinsk Forskningsafsnit, Holstebro | |||||||||||||
Full Title: RENO- OG KREDSLØBSPROTEKTIV EFFEKT AF VITAMIN-D-ANALOG (PARICALCITOL) HOS PATIENTER MED MODERAT TIL SVÆR KRONISK NYREINSUFFICIENS | |||||||||||||
Medical condition: The aim is to measure the effect of paricalcitol given orally in patients with moderate to severe chronic kidney diseases (CKD stage III-IV i.e. eGFR:15-59 ml/min) investigating vasoactive hormones... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021955-14 | Sponsor Protocol Number: BUP3030 | Start Date*: 2011-10-17 | ||||||||||||||||
Sponsor Name:Purdue Pharma L.P. | ||||||||||||||||||
Full Title: A Multicenter, Inpatient, Open-label Study to Characterize the Pharmacokinetics, Safety, and Efficacy of Intravenous Dosing of Buprenorphine in Pediatric Patients Aged from Birth to 6 Years of Age... | ||||||||||||||||||
Medical condition: Acute moderate to severe pain requiring opioids for at least 24 hours in postoperative and prolonged endotracheal intubated patients | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-017155-10 | Sponsor Protocol Number: 10-aifa-2005-01 | Start Date*: 2006-11-07 | |||||||||||
Sponsor Name:CASA DI CURA PRIVATA S.RAFFAELE - PISANA | |||||||||||||
Full Title: Evaluation of tolerability and efficacy of the combination Sildenafil/Bosentan in patients with severe pulmonary hypertension. | |||||||||||||
Medical condition: severe pulmonary hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000424-10 | Sponsor Protocol Number: UC-0130/1703 | Start Date*: 2017-06-16 |
Sponsor Name:UNICANCER | ||
Full Title: A Safety study of Nivolumab in Patients with Recurrent and/or Metastatic Platinum-refractory Squamous Cell Carcinoma of the Head and Neck (SCCHN). | ||
Medical condition: Patients with recurrent and/or metastatic platinum refractory Squamous Cell Carcinoma of the Head and Neck (SCCHN), with poor prognosis and no effective chemotherapy options. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-000667-40 | Sponsor Protocol Number: APD811-003 | Start Date*: 2015-04-23 | |||||||||||
Sponsor Name:Arena Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Randomized, Double-blind, Parallel-group, Placebo-controlled Phase 2 Trial of APD811, an Oral IP Receptor Agonist, in Patients with Pulmonary Arterial Hypertension | |||||||||||||
Medical condition: Pulmonary Arterial Hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) HU (Completed) ES (Completed) PL (Completed) RO (Ongoing) SK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004384-75 | Sponsor Protocol Number: 37970 | Start Date*: 2012-09-10 | ||||||||||||||||
Sponsor Name: | ||||||||||||||||||
Full Title: Randomized controlled trial: Picoprep versus Moviprep for efficacy, safety and patient tolerability in colonoscopy bowel preparation. | ||||||||||||||||||
Medical condition: Patients who need a colonoscopy for screening, surveillance or diagnosis of a disease have to be prepared by bowel cleansing | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001187-33 | Sponsor Protocol Number: ROR-PH-301(APD811-301) | Start Date*: 2019-03-18 | |||||||||||
Sponsor Name:United Therapeutics Corporation | |||||||||||||
Full Title: A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients (ADVANCE Outcomes) | |||||||||||||
Medical condition: pulmonary arterial hypertension (PAH) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) SE (Prematurely Ended) GB (GB - no longer in EU/EEA) HU (Ongoing) DK (Ongoing) PL (Ongoing) CZ (Ongoing) BE (Ongoing) BG (Ongoing) NL (Ongoing) GR (Temporarily Halted) PT (Ongoing) IT (Ongoing) HR (Ongoing) RO (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000789-13 | Sponsor Protocol Number: ISA101b-HN-01-17 | Start Date*: 2019-02-05 | |||||||||||
Sponsor Name:ISA Therapeutics B.V. | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Cemiplimab Versus the Combination of Cemiplimab With ISA101b in the Treatment of Subjects With HPV16-Positive Oropharyngeal Cancer (... | |||||||||||||
Medical condition: HPV16-Positive Oropharyngeal Cancer (OPC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) GB (GB - no longer in EU/EEA) FR (Ongoing) CZ (Completed) ES (Ongoing) BE (Completed) HU (Ongoing) NL (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.